---
title: "Antazoline - Vasomotor Rhinitis - 2"
sidebar: mydoc_sidebar
permalink: db08799-mesh-d012223-2.html
toc: false 
---


Path ID: `DB08799_MESH_D012223_2`
{% include image.html url="images/db08799-mesh-d012223-2.png" file="db08799-mesh-d012223-2.png" alt="db08799-mesh-d012223-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000865 | Antazoline | Drug |
| UniProt:P35367 | Histamine H1 receptor | Protein |
| GO:0034776 | Response to histamine | BiologicalProcess |
| MESH:D013373 | Substance P | ChemicalSubstance |
| MESH:D020078 | Neurogenic Inflammation | Disease |
| MESH:D012223 | Vasomotor rhinitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Antazoline | DECREASES ACTIVITY OF | Histamine H1 Receptor |
| Histamine H1 Receptor | PARTICIPATES IN | Response To Histamine |
| Response To Histamine | INCREASES ABUNDANCE OF | Substance P |
| Substance P | PARTICIPATES IN | Neurogenic Inflammation |
| Neurogenic Inflammation | CONTRIBUTES TO | Vasomotor Rhinitis |
|---------|-----------|---------|

Reference: 
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764847/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764847/)
  - [https://pubmed.ncbi.nlm.nih.gov/18651116/](https://pubmed.ncbi.nlm.nih.gov/18651116/)
  - [https://go.drugbank.com/drugs/DB08799](https://go.drugbank.com/drugs/DB08799)
